Personal CFO Solutions’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $253K | Sell |
2,017
-10
| -0.5% | -$1.26K | 0.05% | 384 |
|
|
2025
Q1 | $277K | Buy |
2,027
+482
| +31% | +$66K | 0.06% | 337 |
|
|
2024
Q4 | $236K | Sell |
1,545
-37
| -2% | -$5.66K | 0.05% | 395 |
|
|
2024
Q3 | $307K | Buy |
1,582
+243
| +18% | +$47.1K | 0.04% | 416 |
|
|
2024
Q2 | $310K | Buy |
1,339
+160
| +14% | +$37.1K | 0.05% | 366 |
|
|
2024
Q1 | $254K | Buy |
1,179
+155
| +15% | +$33.4K | 0.04% | 444 |
|
|
2023
Q4 | $265K | Buy |
1,024
+16
| +2% | +$4.14K | 0.05% | 406 |
|
|
2023
Q3 | $259K | Buy |
1,008
+29
| +3% | +$7.45K | 0.05% | 361 |
|
|
2023
Q2 | $279K | Sell |
979
-39
| -4% | -$11.1K | 0.06% | 347 |
|
|
2023
Q1 | $283K | Buy |
1,018
+67
| +7% | +$18.6K | 0.06% | 327 |
|
|
2022
Q4 | $263K | Buy |
951
+92
| +11% | +$25.5K | 0.06% | 339 |
|
|
2022
Q3 | $229K | Buy |
+859
| New | +$229K | 0.06% | 325 |
|
|
2021
Q4 | – | Sell |
-2,829
| Closed | -$801K | – | 478 |
|
|
2021
Q3 | $801K | Sell |
2,829
-22
| -0.8% | -$6.23K | 0.16% | 131 |
|
|
2021
Q2 | $987K | Buy |
2,851
+187
| +7% | +$64.7K | 0.2% | 102 |
|
|
2021
Q1 | $745K | Buy |
2,664
+392
| +17% | +$110K | 0.16% | 119 |
|
|
2020
Q4 | $556K | Buy |
2,272
+6
| +0.3% | +$1.47K | 0.14% | 137 |
|
|
2020
Q3 | $1K | Sell |
2,266
-75
| -3% | -$33 | 0.33% | 61 |
|
|
2020
Q2 | $626K | Buy |
2,341
+149
| +7% | +$39.8K | 0.19% | 107 |
|
|
2020
Q1 | $694K | Buy |
2,192
+28
| +1% | +$8.87K | 0.25% | 92 |
|
|
2019
Q4 | $642K | Buy |
+2,164
| New | +$642K | 0.18% | 114 |
|